Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Stopped Slow accrual and company withdrawing support to supply the drug
Conditions
- Brain and Central Nervous System Tumors
- Carcinoma of Unknown Primary
- Leukemia
- Lymphoma
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- DRUG: topotecan hydrochloride
Sponsor
Pediatric Brain Tumor Consortium
Collaborators